We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

By LabMedica International staff writers
Posted on 15 Feb 2024

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. More...

A promising development in this area is the photoacoustic (PA) technique. Over the past decade, PA imaging has gained traction as a practical imaging modality in various clinical settings where it has demonstrated encouraging results. While traditional diagnostic methods are invasive, PA imaging offers a noninvasive alternative for examining biological tissues. However, its broad clinical application has been hampered by the bulkiness and high cost of laser sources. Now, researchers have introduced a groundbreaking, compact, and affordable PA sensing instrument for biomedical tissue diagnosis. Their proof-of-concept study, utilizing cost-effective diode lasers, marks a significant step toward the transition of PA imaging from laboratory research to clinical application.

For the study, researchers from the IIT Indore (Madhya Pradesh, India) focused on the complex nature of breast tissue, specifically fibrocystic changes, which often present diagnostic challenges due to similarities with breast cancer. These changes can cause breast pain and detectable cysts and are frequently found in peritumoral breast parenchyma, complicating diagnoses. Traditional diagnostic methods like ultrasound and mammography sometimes lack the necessary precision, and fine needle aspiration cytology, a common diagnostic tool, often requires additional invasive procedures for confirmation. The PA technique, leveraging laser diodes, generates acoustic waves that provide critical insights into tissue composition and density.

The novel instrument incorporates multiple laser diodes in a compact design, coupled with a custom-built pulsed current supply unit, producing efficient PA excitation with 25 nanosecond pulses at 20 kHz. The researchers were able to distinguish between normal and diseased breast tissues by analyzing the frequency spectra of PA signals. Analyzing the frequency spectra allowed for quantitative tissue assessment. For example, fibrocystic breast disease showed a dominant frequency peak at around 1.60 MHz, suggesting increased tissue density, while normal breast tissue had a lower peak frequency of 0.26 MHz, indicative of its fibrofatty composition.

Histopathological examinations confirmed these observations, aligning spectral responses with tissue characteristics. The experimental setup differentiated tissue types based on quantitative spectral parameters, enhancing diagnostic accuracy and potentially simplifying the sampling process for pathological breast tissues. The compact PA sensing instrument could emerge as a promising tool for clinical practice, offering rapid, reliable, and cost-effective breast disease diagnosis. This breakthrough paves the way for timely interventions and improved patient outcomes, revolutionizing biomedical practices with a cost-effective and rapid tissue diagnosis approach.

Related Links:
IIT Indore


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Automated Urinalysis Solution
UN-9000
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.